PreciControl HBsAg II - Hepatitis B virus surface antigen IVD, control
Country: Awstralja
Lingwa: Ingliż
Sors: Department of Health (Therapeutic Goods Administration)
Rapport ta 'Valutazzjoni Pubblika
(PAR)
22-11-2017
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Disponibbli minn:
Roche Diagnostics Australia Pty Limited
Klassi:
Class 4
Manifatturat minn:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Żona terapewtika:
42000 - Hepatitis B virus surface antigen IVD, control
Indikazzjonijiet terapewtiċi:
A ready to use control serum based on human serum both in the negative and positive concentration range. For quality control of the Elecsys HBsAg II and Elecsys HBsAg II Auto Confirm immunoassays on the Elecsys and cobas e immunoassay analysers.
L-istatus ta 'awtorizzazzjoni:
A
Data ta 'l-awtorizzazzjoni:
2013-09-13
